FDA has released a white paper outlining a potential regulatory framework for software as a medical device (SaMD) that leverages artificial intelligence (AI) or machine learning (ML). The white paper ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results